PD-L1 NewsLatest News On PD-L1 Exosomes: A double-edged sword in hepatocellular carcinoma12/12/2024 2:20 AM TCR sequencing sheds light on tumor immune interactions in hepatocellular carcinoma12/11/2024 3:02 PM Cancer therapy may raise heart attack and stroke risks by disrupting immune regulation in arteries12/4/2024 1:48 PM Phase 1 study finds serine- and glycine-free diet boosts immune response in colorectal cancer11/29/2024 3:56 PM PD-1 deficiency reveals the impact of checkpoint inhibition on B cell function11/27/2024 7:13 AM Breakthrough in protein engineering may lead to more effective cancer therapies Scientists At A...11/17/2024 1:07 AM Novel bladder cancer treatment gains MHRA approval in the UK11/9/2024 10:24 AM Targeting ferroptosis for overcoming chemoresistance in digestive tract tumors11/8/2024 4:32 PM Targeted therapy and immunotherapy improve outcomes in rare thyroid cancer10/24/2024 7:56 PM Dual immunotherapy plus chemotherapy shows promise for specific lung cancer patients10/10/2024 2:08 AM The role of FOXM1 and PD-L1 in malignant peripheral nerve sheath tumor resistance10/1/2024 7:31 PM Targeting tumor immunity with transferrin receptor-directed photodynamic therapy9/26/2024 11:11 AM FORT-2 trial shows promising results for bladder cancer immunotherapy combination9/20/2024 1:00 AM Advances in targeting the CD47/SIRPα 'do not eat me' pathway for cancer therapy9/13/2024 5:37 PM Auburn University researchers develop AI-driven method to target cancer proteins9/6/2024 3:17 AM EZH2's role in cancer progression and therapy explored8/10/2024 12:23 AM Review of fasting-mimicking diets in cancer treatment8/8/2024 1:16 PM FDA accepted PD-L1 inhibitor durvalumab for the treatment of endometrial cancer8/5/2024 5:24 AM Researchers identify shared molecular mechanism in cancer and pregnancy that suppresses immune system7/11/2024 11:26 AM Insilico Medicine's AI-driven approach yields promising PTPN2/N1 inhibitor for cancer immunotherapy4/14/2024 6:27 AM
